Effect of selenium on ''low T3 syndrome '' in hepatic failure

Kaynakça (1)

1. Coombs GF., Coombs SB. Selenium andCancer. In: Coombs GF., ed. The role ofselenium in nutrition, Academic Press,Orlando, 1986, 413–61. 2.L’Abbe MR., Fischer PWF., Cambelli JS.,Chavez ER. Effects of dietary seleniumon DMBA–induced carcinogenesis inrats fed a diet high in mixed fats. J Nutr119: 757–65, 1989. 3.Halverson AW. Growth andreproduction with rats fed selenite–Se.Proc S Dakota Acad Sci 53: 167–77,1974. 4.Willet WC., Morris JS., Pressel S.,Taylor JO., Polk BF., Stampfer MJ.Prediagnostic serum selenium and riskof cancer. Lancet 2: 130–4, 1985. 5.Har JR., Exon JH., Whanger PD.,Weswig PH. Effect of dietarysupplementation on N–2–fluorenyl–acetamide (FAA)–induced cancer invitamin E supplemented seleniumdepleted rats. Clin Toxicol 5: 187–94,1972. 6.Beckett GJ., Beddows SE., MorricePC., Nicol F., Arthur JR. Inhibition ofhepatic deiodination of thyroxine iscaused by selenium deficiency in rats.Biochem J 248: 443–7, 1987 7.Beckett GJ., Nicol F., Proudfoot D.,Dyson K., Loucaides G., Arthur JR. Thechanges in hepatic enzyme expressioncaused by selenium deficiency andhypothyroidism in rats are produced byindependent mechanisms. Biochem J266: 743–7, 1990. 8.Meinhold H., Campos–Barros A.,Walzog B., Köhler R., Müller F. Effectsof selenium and iodine deficiency ontype I, type II, and type III iodothyroninedeiodinases and circulating thyroidhormone in rats. Exp Clin Endocrinol101: 87–93, 1993. 9.Beckett GJ., Russel A., Nicol F., SahuP., Wolf C., Arthur JR. Effect ofselenium deficiency on hepatic type I5–iodothyronine deiodinase activityand hepatic thyroid hormone level inthe rat. Biochem J 282: 483–6, 1992. 10.Chanoine JP., Safran M., Farwel AP.,Dubord S., Alex S., Stone S. Effects ofselenium deficiency on thyroidhormone economy in rats. Endocrinol131: 1787–92, 1992. 11.Chopra IJ. A study of extrathyroidalconversion by thyroxine (T4) to 3, 3’,5–triiodothyronine (T3) in vitro.Endocrinol 101: 453–63, 1977. 12.Kabadi UM., Premachandra BN. Lowserum T3 and raised reverse T3 levelsin hepatic cirrhosis: role of glucagon. J.Gastroenterol 86: 1504–7, 1991. 13.Arthur JR., Morrice PC., Nicol F.,Beddows SE., Boyd R., Hayes JD.,Beckett GJ. The effects of selenium andcopper deficiencies on glutathioneS–transferase and glutathioneperoxidase in rat liver. Biochem J 248:539–44, 1987. 14.Burman KD., Smallridge RC., Jones L.,Ramos EA. Glucagon kinetics infasting: Physiological elevation inserum 3, 5, 3’–triiodothyronineincrease the metabolic clearence rate ofglucagon. J Clin Endocrino